In several neurodegenerative diseases, including Alzheimer’s disease and other tauopathies (Suberbielle et al., 2015; Kurihara et al., 2020), BRCA1 dysregulation and mislocalization have also been reported. This evidence concerns the gene BRCA1 and early-onset autosomal dominant Alzheimer disease.